 |
|
Could Early Anti-Tumor Necrosis Factor Therapy Change the Prognosis of Crohn's Disease?
Byong Duk Ye
Intest Res. 2014;12(4):263-265. Published online 2014 Oct 27 DOI: https://doi.org/10.5217/ir.2014.12.4.263
|
|
Citations to this article as recorded by
 Therapeutic strategies in Crohn’s disease in an emergency surgical setting
Maria Michela Chiarello, Gilda Pepe, Valeria Fico, Valentina Bianchi, Giuseppe Tropeano, Gaia Altieri, Giuseppe Brisinda
World Journal of Gastroenterology.2022; 28(18): 1902. CrossRef Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study
Jooyoung Lee, Jong Pil Im, Kyungdo Han, Seona Park, Hosim Soh, Kukhwan Choi, Jihye Kim, Jaeyoung Chun, Joo Sung Kim
World Journal of Gastroenterology.2019; 25(42): 6354. CrossRef Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study
Chang Mo Moon, Sung-Ae Jung, Seong-Eun Kim, Hyun Joo Song, Yunho Jung, Byong Duk Ye, Jae Hee Cheon, You Sun Kim, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Mathias Chamaillard
PLOS ONE.2015; 10(12): e0144390. CrossRef Post-marketing study of biosimilar infliximab (CT-P13) to evaluate its safety and efficacy in Korea
Sang Hyoung Park, Young-Ho Kim, Ji Hyun Lee, Hyeok Jin Kwon, Suck-Ho Lee, Dong Il Park, Hyung Kil Kim, Jae Hee Cheon, Jong Pil Im, You Sun Kim, Sung Young Lee, Sang Joon Lee
Expert Review of Gastroenterology & Hepatology.2015; 9(sup1): 35. CrossRef The clinical characteristics of patients with free perforation in Korean Crohn’s disease: results from the CONNECT study
Young Seok Doh, You Sun Kim, Song I Bae, Jong Pil Im, Jae Hee Cheon, Byong Duk Ye, Ji Won Kim, Young Sook Park, Ji Hyun Lee, Young-Ho Kim, Joo Sung Kim, Dong Soo Han, Won Ho Kim
BMC Gastroenterology.2015;[Epub] CrossRef
|